ARK Genomic Revolution ETF

The investment seeks longterm growth of capital. The fund is an activelymanaged exchangetraded fund ETF that will invest under normal circumstances primarily at least 80% of its assets in domestic and foreign equity securities of companies across multiple sectors including healthcare information technology materials energy and consumer discretionary that are relevant to the funds investment theme of the genomics revolution Genomics Revolution Companies. It is nondiversified. The fund is an actively-managed exchange-traded fund (ETF) that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the funds investment theme of the genomics revolution (Genomics Revolution Companies). It is non-diversified.